Clinical Trials in Oklahoma City, OK | Oklahoma City Clinical Drug Trials & Studies

You are viewing Clinical Trials In Oklahoma City, OK

Have multiple conditions? Click here

Showing 1-100 of 372

There are 372 trials in Oklahoma

Name	City	State	Zip
Paclitaxel in Treating Patients With Ovarian Stromal Cancer	Oklahoma City	OK	73104
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Oklahoma City	OK	73104
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma	Oklahoma City	OK	73104
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Oklahoma City	OK	73104
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer	Oklahoma City	OK	73104
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer	Oklahoma City	OK	73104
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Oklahoma City	OK	73104
Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Oklahoma City	OK	73104
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia	Oklahoma City	OK	73104
Study of Late-Occurring Complications in Childhood Cancer Survivors	Oklahoma City	OK	73104
Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)	Oklahoma City	OK	73104
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Oklahoma City	OK	73104
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer	Oklahoma City	OK	73104
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Oklahoma City	OK	73104
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer	Oklahoma City	OK	73104
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Oklahoma City	OK	73104
Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission	Oklahoma City	OK	73104
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer	Oklahoma City	OK	73104
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor	Oklahoma City	OK	73104
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant	Oklahoma City	OK	73104
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Oklahoma City	OK	73104
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Oklahoma City	OK	73104
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma	Oklahoma City	OK	73104
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma	Oklahoma City	OK	73104
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Oklahoma City	OK	73104
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Oklahoma City	OK	73104
Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes	Oklahoma City	OK	73104
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Oklahoma City	OK	73104
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Oklahoma City	OK	73104
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission	Oklahoma City	OK	73104
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Oklahoma City	OK	73104
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Oklahoma City	OK	73104
Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer	Oklahoma City	OK	73104
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Oklahoma City	OK	73104
Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	Oklahoma City	OK	73104
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Oklahoma City	OK	73104
Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery	Oklahoma City	OK	73104
Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)	Oklahoma City	OK	73104
Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer	Oklahoma City	OK	73104
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Oklahoma City	OK	73104
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Oklahoma City	OK	73104
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors	Oklahoma City	OK	73104
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission	Oklahoma City	OK	73104
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Oklahoma City	OK	73104
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia	Oklahoma City	OK	73104
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma	Oklahoma City	OK	73104
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma	Oklahoma City	OK	73104
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Studying Biomarkers in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells	Oklahoma City	OK	73104
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer	Oklahoma City	OK	73104
Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma	Oklahoma City	OK	73104
Collecting Tumor Samples From Patients With Gynecological Tumors	Oklahoma City	OK	73104
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Oklahoma City	OK	73104
Study of Kidney Tumors in Young Patients	Oklahoma City	OK	73104
Collecting and Storing Tissue From Young Patients With Cancer	Oklahoma City	OK	73104
Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy	Oklahoma City	OK	73104
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes	Oklahoma City	OK	73104
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma	Oklahoma City	OK	73104
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma	Oklahoma City	OK	73104
Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma	Oklahoma City	OK	73104
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Oklahoma City	OK	73104
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Oklahoma City	OK	73104
Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors	Oklahoma City	OK	73104
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy	Oklahoma City	OK	73104
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer	Oklahoma City	OK	73104
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Oklahoma City	OK	73104
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor	Oklahoma City	OK	73104
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer	Oklahoma City	OK	73104
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer	Oklahoma City	OK	73104
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Study of Blood Samples From Newborns With Down Syndrome	Oklahoma City	OK	73104
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Oklahoma City	OK	73104
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer	Oklahoma City	OK	73104
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer	Oklahoma City	OK	73104
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy	Oklahoma City	OK	73104
Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma	Oklahoma City	OK	73104
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	Oklahoma City	OK	73104
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma	Oklahoma City	OK	73104
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer	Oklahoma City	OK	73104
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma	Oklahoma City	OK	73104
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	Oklahoma City	OK	73104
AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors	Oklahoma City	OK	73104
Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma	Oklahoma City	OK	73104
Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	Oklahoma City	OK	73104
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer	Oklahoma City	OK	73104
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma	Oklahoma City	OK	73104
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer	Oklahoma City	OK	73104
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery	Oklahoma City	OK	73104
EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Oklahoma City	OK	73104
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Oklahoma City	OK	73104
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Oklahoma City	OK	73104
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Oklahoma City	OK	73104
Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer	Oklahoma City	OK	73104
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia	Oklahoma City	OK	73104
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer	Oklahoma City	OK	73104
A Cardiac Safety Study of Tivozanib to Evaluate the Electrocardiogram and Pharmacokinetic-Electrocardiogram Dynamics in Subjects With Advanced Solid Tumors	Oklahoma City	OK	73104

View Clinical Trial Facilities in Oklahoma

Showing 1-100 of 372

helpful resources

share this page

Clinical Studies in Oklahoma City, Oklahoma

Oklahoma City does indeed happen to be the capital of the state of Oklahoma, one of only a handful of other state’s/capital’s which share a name. The city also happens to house one of the largest livestock markets in the world. This city is a part of a metropolitan area that has a population of more than one million.

New clinical trials in Oklahoma City, OK are providing researchers with a very diverse patient population to work with. In some areas this can be difficult to accomplish, however the facilities conducting these paid clinical studies in Oklahoma City are not lacking in available resources. This may very soon lead to incredible medical breakthroughs which could improve the quality of life for people all over the world. Certified clinical research coordinators are supervising these Oklahoma City clinical trials and are collaboratively working toward discovering better treatments and eventually cures.